A UK survey of the experience of service provision for children and young people with epilepsy

There has been increasing acknowledgement of the need to include patients’ experiences in evaluation of healthcare and that monitoring healthcare effectiveness from the patient perspective can be as important as using clinical outcome measures to enable quality improvement [1]. The World Health Organisation emphasises the importance of understanding patient satisfaction and responsiveness to care experiences. Patient satisfaction with aspects of non-medical care is associated with better engagement with treatment, appropriate care-seeking and understanding and retention of medical information [2].

Seguir leyendo →
0

BIOCHEMICAL DERANGEMENTS RELATED TO METABOLIC SYNDROME IN EPILEPTIC PATIENTS ON TREATMENT WITH VALPROIC ACID

Valproate (VPA), a branched chain fatty acid, is a broad spectrum anticonvulsant used for the treatment of epilepsy such as generalized and partial seizures [1]. Continuous administration of antiepileptic drugs results in long standing complications such as psychiatric disorders, metabolic disorder, endocrine disorders, idiosyncratic reactions and drug interaction effects in some cases [2]. Valproate is metabolized in the liver by glucuronidation process and to a lesser extent by β oxidation. [3].

Seguir leyendo →
0

The Quality of Life of the Elderly with Epilepsy: A Systematic Review

The life expectancy of the population has increased due to improvements in medicine, public health, nutrition, income, education, and migration [1]. Between 2015 and 2030, “The number of people in the world aged 60 and over is expected to grow by 56%, from 901 million to 1.4 billion” [2]. Consequently, long-term care and age-related chronic illness increases in addition to treatment of disease, resulting in longer life expectancy. The quality of a persons’ life has been shown to be of ...

Seguir leyendo →
0

Functional network changes in the hippocampus contribute to depressive symptoms in epilepsy

Depression is highly common in patients with epilepsy, with a prevalence of approximately 30% in patients with recurrent seizures [1]. Depression not only negatively affects patient quality of life but is also correlated with cognitive functioning in patients with epilepsy [2,3]. However, the mechanisms underlying the comorbidity of epilepsy and depression remain unclear. Evidence from clinical and laboratory research indicates that there are common pathogenic mechanisms associated with epilepsy and depression [4].

Seguir leyendo →
0
Página 135 de 182 «...110120130133134135136137...»